Euflexxa is used to relieve knee pain due to osteoarthritis. It helps patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics. This product is injected into the knee. It contains sodium hyaluronate. The manufacturer of this product is Ferring.
Durolane 60mg/3ml is a clear, viscous injectable gel consisting of highly-purified hyaluronic acid. Clinically, Durolane 60mg/3ml is indicated for the treatment of OA knee pain in osteoarthritis in those who have responded inadequately to simple analgesics like acetaminophen, or conservative non-pharmacological therapy. Durolane 60mg/3ml is a product of Q-Med AB.
Crespine Gel Plus is a viscoelastic, apyrogenic gel implant. It contains hyaluronic acid, a polysaccharide produced through the process of fermentation. Crespine Gel Plus is often used in the treatment of pain and join function conditions caused by degenerative deficits. This orthopedic injection is made by BioPolymer, a leading manufacturer of hyaluronic acid gel.
Orthovisc is a sterile, non-pyrogenic solution of sodium hyaluronate. The sodium hyaluronate in Orthovisc functions as a tissue lubricant, and is thought to play an important role in modulating the interactions between tissues. It can also act as a viscoelastic support for maintaining separation between tissues. Orthovisc is indicated as a viscoelastic supplement or a replacement for synovial fluid in human joints. It is well suited for treatment of the symptoms of human synovial joint dysfunctions, such as osteoarthritis. The actions of Orthovisc are lubrication and mechanical support.
Hymovis is an injectable gel that is used to treat pain associated with knee osteoarthritis. Made of proprietary and highly modified hyaluronan that has enhanced lubricating and shock absorption abilities, Hymovis can provide long-lasting pain relief in a simple two-injection regimen. Hymovis is manufactured by Fidia.
Cingal is a hyaluronic acid gel that contains micronized steroid particles. In patients who are unresponsive to pain medications (or conservative non-pharmacologic therapy), Cingal is injected intra-articularly to treat knee pain associated with osteoarthritis (OA). This orthopedic injection is manufactured by a Bedford-based pharmaceutical company known as Anika Therapeutics, Inc.
Synvisc One is an osteoarthritis treatment that contains hylan, a natural found in the synovial fluid of the joints. When injected directly into the joints, Synvisc One acts as a replacement for synovial fluid. The therapeutic effect of this treatment is achieved through viscosupplementation, a process in which the rheological and physiological state of arthritic joint tissues are reestablished. This increases mobility of the joint through decreased pain and inflammation.
Synvisc is a sterile, non-pyrogenic, elastoviscous fluid containing hylan. Hylan is a derivative of hyaluronan, which is responsible for the elastoviscosity of synovial fluid in the joints. With this, Synvisc injections may be used as a temporary replacement and supplement for synovial fluid.
Synvisc achieves its therapeutic effect through viscosupplementation, a process whereby physiological and rheological states of the arthritic joint tissues are restored. Viscosupplementation with Synvisc decreases joint pain and discomfort, allowing more extensive movemen
Supartz is used to treat knee pain in patients with joint inflammation or osteoarthritis. It is usually used in patients who have not responded to other forms of arthritis treatment, such as acetaminophen, exercise, and physical therapy. Supartz works as a lubricant and shock absorber in the knee joint, helping it to move smoothly and with less pain. While Supartz treatment is approved for 5 weekly injections, physicians may tailor this treatment to each patient’s individual needs.